COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,761 Articles (22,946 medRxiv, 8,815 bioRxiv)

Most recent first Previous |  Page 1666: Articles 16651-16660  | Next

A distinct metabolic profile associated with a fatal outcome in COVID-19 patients during early epidemic in Italy
Saccon, E., Bandera, A., Sciume, M., Mikaeloff, F., Lashari, A. A., Aliberti, S., Sachs, M., Billi, F., Blasi, F., Gabriel, E., Costantino, G., Deroberto, P., Krishnan, S., Gori, A., Peyvandi, F., Scudeller, L., Lorson, C. L., Valenti, L., Singh, K., Baldini, L., Fracchiolla, N. S., Neogi, U.
10.1101/2021.04.13.21255117 — Posted: 2021-04-15
Protocol for the COG-UK hospital onset COVID-19 infection (HOCI) multicentre interventional clinical study: evaluating the efficacy of rapid genome sequencing of SARS-CoV-2 in limiting the spread of COVID-19 in United Kingdom NHS hospitals
Blackstone, J., Stirrup, O., Mapp, F., Panca, M., Copas, A., Flowers, P., Hockey, L., Price, J. R., Partridge, D. G., Peters, C., de Silva, T., Nebbia, G., Snell, L. B., McComish, R., COVID-19 Genomics UK (COG-UK) Consortium, , Breuer, J.
10.1101/2021.04.13.21255342 — Posted: 2021-04-15
Efficacy of a nasal spray containing Iota-Carrageenan in the prophylaxis of COVID-19 in hospital personnel dedicated to patients care with COVID-19 disease. A pragmatic multicenter, randomized, double-blind, placebo-controlled trial (CARR-COV-02)
Figueroa, J. M., Lombardo, M., Dogliotti, A., Flynn, L., Giugliano, R. P., Simonelli, G., Valentini, R., Ramos, A., Romano, P., Marcote, M., Michelini, A., Salvado, A., Sykora, E., Kniz, C., Kobelinsky, M., Salzberg, D., Jerusalinsky, D., Uchitel, O., CARR-COV2 Trial Group
10.1101/2021.04.13.21255409 — Posted: 2021-04-15 Discussion: Onsite
Use of Modeling to Inform Decision-Making During the COVID-19 Pandemic: A Qualitative Study
Johnson, K., Biddell, C., Hassmiller Lich, K., Swann, J., Delamater, P., Mayorga, M., Ivy, J., Smith, R., Patel, M.
10.1101/2021.04.13.21255401 — Posted: 2021-04-15
Seroepidemiology among Employees of New York City Health and Hospitals during the First Wave of the SARS-CoV-2 Epidemic
Bryan, A. D., Tatem, K., Diuguid-Gerber, J., Cooke, C., Romanoff, A., Choudhury, N., Scanlon, M., Kishore, P., Sydney, E., Masci, J., Bakshi, P., Pemmasani, S., Davis, N. J., Maru, D.
10.1101/2021.04.12.21255344 — Posted: 2021-04-15
Trajectories of compliance with COVID-19 related guidelines: longitudinal analyses of 50,000 UK adults
Wright, L., Steptoe, A., Fancourt, D.
10.1101/2021.04.13.21255336 — Posted: 2021-04-15
Do people reduce compliance with COVID-19 guidelines following vaccination? A longitudinal analysis of matched UK adults
Wright, L., Steptoe, A., Mak, H. W., Fancourt, D.
10.1101/2021.04.13.21255328 — Posted: 2021-04-15
Covid-19: Early evening curfews are not effective and may backfire
Vandoros, S., Velias, A., Georganas, S.
10.1101/2021.04.13.21255091 — Posted: 2021-04-15
Breakpoint modelling of temporal associations between non-pharmaceutical interventions and the incidence of symptomatic COVID-19 in the Republic of Ireland
Boudou, M., O'Dwyer, J., Oh'Aiseadha, C., Hynds, P.
10.1101/2021.04.12.21255297 — Posted: 2021-04-15
Quarantine, relaxation and mutation explaining the CoViD-19 epidemic in Sao Paulo State (Brazil)
Yang, H. M., Lombardi Junior, L. P. P., Castro, F. F. M., Yang, A. C.
10.1101/2021.04.12.21255325 — Posted: 2021-04-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).